Polymorphism in the IL6 promoter region is associated with the risk factors and markers of subclinical atherosclerosis in men: The Cardiovascular Risk in Young Finns Study.

[1]  Eric Boerwinkle,et al.  The Atherosclerosis Risk in Communities (ARIC) Study , 2011 .

[2]  A. Hofman,et al.  TGF-&bgr;1 Polymorphisms and Risk of Myocardial Infarction and Stroke: The Rotterdam Study , 2006, Stroke.

[3]  Richard B Devereux,et al.  Preclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis , 2006, Annals of Internal Medicine.

[4]  A. Hofman,et al.  Interleukin 6 −174 G/C Promoter Polymorphism and Risk of Coronary Heart Disease: Results from the Rotterdam Study and a Meta-Analysis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[5]  E. Porcellini,et al.  Interleukin‐6 gene polymorphism is an age‐dependent risk factor for myocardial infarction in men , 2005, International journal of immunogenetics.

[6]  M. Boemi,et al.  The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. , 2005, International journal of cardiology.

[7]  T. Lehtimäki,et al.  Interleukin-6 −174G/C polymorphism and longevity: a follow-up study , 2005, Mechanisms of Ageing and Development.

[8]  F. Licastro,et al.  The concomitant presence of polymorphic alleles of interleukin-1β, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men: Results from a pilot study , 2004 .

[9]  F. Licastro,et al.  The concomitant presence of polymorphic alleles of interleukin-1β, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men Results from a pilot study , 2004, Mechanisms of Ageing and Development.

[10]  M. Hersberger,et al.  High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease , 2004, Current opinion in lipidology.

[11]  J. Viikari,et al.  The 21‐year follow‐up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east–west difference , 2004, Journal of internal medicine.

[12]  H. Yoshimatsu,et al.  Brachial arterial stiffness predicts coronary atherosclerosis in patients at risk for cardiovascular diseases. , 2004, Japanese heart journal.

[13]  T. Laitinen,et al.  Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. , 2003, JAMA.

[14]  D. Webb,et al.  Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[15]  I. Vauhkonen,et al.  The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. , 2003, Diabetes.

[16]  S. Humphries,et al.  In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[17]  S. Humphries,et al.  Interleukin-6 −174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS) , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[18]  R. Reading.  Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study , 2002 .

[19]  E. Hawe,et al.  The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. , 2001, European heart journal.

[20]  O. Pappo,et al.  Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6-secreting tumor. , 2001, American journal of physiology. Endocrinology and metabolism.

[21]  C. Franceschi,et al.  A gender–dependent genetic predisposition to produce high levels of IL‐6 is detrimental for longevity , 2001, European journal of immunology.

[22]  Sagiv Shifman,et al.  The value of isolated populations , 2001, Nature Genetics.

[23]  A. Pasternack,et al.  Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. , 2001, Rheumatology.

[24]  M. Hurme,et al.  The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. , 2001, European cytokine network.

[25]  A. Evans,et al.  Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study , 2001, Journal of Molecular Medicine.

[26]  James D. Cameron,et al.  Effects of Blood Pressure, Smoking, and Their Interaction on Carotid Artery Structure and Function , 2001, Hypertension.

[27]  C. Bouchard,et al.  Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[28]  M E Safar,et al.  Arterial Mechanical Changes in Children With Familial Hypercholesterolemia , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[29]  D. Papanicolaou,et al.  Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. , 2000, The Journal of clinical endocrinology and metabolism.

[30]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[31]  T Foitzi,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay , 1999 .

[32]  T Varilo,et al.  Molecular genetics of the Finnish disease heritage. , 1999, Human molecular genetics.

[33]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[34]  J. Blacher,et al.  Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. , 1998, Hypertension.

[35]  P M Rautaharju,et al.  Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. , 1995, Stroke.

[36]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[37]  T. Lehtimäki,et al.  Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study. , 1990, Journal of lipid research.

[38]  J. Viikari,et al.  Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross‐sectional study of 1980, and an account of the children's and families' state of health , 1985, Acta paediatrica Scandinavica. Supplement.